AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Helix BioPharma Corp.

CAD 1.4 -$1.00 (-41.67%)
TSX · 15 Sep 2026 13:30 UTC
Previous Close
CAD 1.4
Day Range
CAD 1.4 - CAD 1.4
Year Range
CAD 1.1CAD 5.4
Market Cap
106.93M
AVG Volume
1.77K
Trailing/Forward PE
-31.82/-
PEG ratio
-0.12
Dividend Yield
-
Next Earnings Date
2026-10-29
Primary Exchange
Toronto Stock ExchangeCA
Revenue (CAD)
00.250.50.75124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Revenue (CAD) by quarter
PeriodRevenue (CAD)
26 Q30
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
Net Income (CAD)
-6M-4M-2M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Net Income (CAD) by quarter
PeriodNet Income (CAD)
26 Q3-671K
26 Q2-694K
26 Q1-1.01M
25 Q4-950K
25 Q3-1.54M
25 Q2-1.38M
25 Q1-1.34M
24 Q4-5.28M
24 Q3-1.83M
24 Q2-902K
Operating Income (CAD)
-6M-4M-2M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
26 Q3-690K
26 Q2-682K
26 Q1-943K
25 Q4-986K
25 Q3-1.55M
25 Q2-1.29M
25 Q1-1.59M
24 Q4-5.29M
24 Q3-1.82M
24 Q2-902K
EBITDA (CAD)
-6M-4M-2M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
26 Q3-689K
26 Q2-681K
26 Q1-1.01M
25 Q4-704K
25 Q3-1.54M
25 Q2-1.37M
25 Q1-1.33M
24 Q4-5.3M
24 Q3-1.83M
24 Q2-877K
Cash Flows (CAD)
-1.5M-1M-500K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
26 Q3-880K
26 Q2-456K
26 Q1-1.22M
25 Q4-649K
25 Q3-1.38M
25 Q2-942K
25 Q1-861K
24 Q4-750K
24 Q3-1.12M
24 Q2-1.49M
EPS (CAD)
-0.15-0.1-0.05-024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO EPS (CAD) by quarter
PeriodEPS (CAD)
26 Q3-0.01
26 Q2-0.01
26 Q1-0.01
25 Q4-0.01
25 Q3-0.15
25 Q2-0.14
25 Q1-0.14
24 Q4-0.11
24 Q3-0.04
24 Q2-0.02
Expenses (CAD)
02M4M6MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Expenses (CAD) by quarter
PeriodExpenses (CAD)
26 Q3689K
26 Q2681K
26 Q1941K
25 Q4985K
25 Q31.01M
25 Q2870K
25 Q11.35M
24 Q45.29M
24 Q31.82M
24 Q2899K
Cash & Debt (CAD)
01M2M3MCashLong Term DebtShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
26 Q32.84M
26 Q231K
26 Q1498K
25 Q465K
25 Q3715K
25 Q22M
25 Q1228K
24 Q41.08M
24 Q3710K
24 Q2120K
Debt ratios
-0.2500.250.50.75124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Debt ratios by quarter
PeriodDebt ratios
26 Q30.81
26 Q2-0.08
26 Q10.03
25 Q4-0.05
25 Q30.07
25 Q20.2
25 Q10.02
24 Q40.12
24 Q30.12
24 Q20.02
Margins
0%50%100%150%17 Q1
HBP.TO Margins by quarter
PeriodMargins
17 Q1100%
Return on Capital
-2000%0%2000%4000%6000%8000%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Return on Capital by quarter
PeriodReturn on Capital
26 Q3-4.57%
26 Q2-4.52%
26 Q1-6.27%
25 Q4-6.1%
25 Q3111.08%
25 Q27236.84%
25 Q197.95%
24 Q45864.44%
24 Q3508.61%
24 Q2348.26%
Shares Outstanding
020M40M60M80M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Shares Outstanding by quarter
PeriodShares Outstanding
26 Q376.38M
26 Q276.38M
26 Q175.87M
25 Q474.16M
25 Q310.01M
25 Q210.01M
25 Q19.8M
24 Q447.98M
24 Q342.63M
24 Q241.98M
Book Value Per Share (CAD)
-0.2-0.100.10.20.324 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
26 Q30.19
26 Q20.2
26 Q10.21
25 Q40.21
25 Q3-0.14
25 Q2-0
25 Q1-0.14
24 Q4-0
24 Q3-0.01
24 Q2-0.01
Total Assets (CAD)
010M20M30M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
HBP.TO Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
26 Q321.38M
26 Q218.52M
26 Q119.07M
25 Q418.8M
25 Q31.01M
25 Q22.24M
25 Q1414K
24 Q41.49M
24 Q31.15M
24 Q2344K
Free Cash Flow Yield
-60%-40%-20%0%med -11.19%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
HBP.TO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-3%
Sep 26-2.9%
Sep 26-2.33%
Aug 26-2.21%
Aug 26-2.13%
Aug 26-2.25%
Aug 26-2.62%
Jul 26-2.8%
Jul 26-3.42%
Jul 26-3.47%
Jul 26-3.37%
Jul 26-3.47%
Jun 26-3.35%
Jun 26-3.42%
Jun 26-3.07%
Jun 26-3.07%
May 26-2.98%
May 26-2.98%
May 26-3.07%
May 26-2.96%
May 26-2.3%
Apr 26-2.83%
Apr 26-2.78%
Apr 26-2.94%
Apr 26-3.25%
Mar 26-3%
Mar 26-3.35%
Mar 26-2.78%
Mar 26-2.66%
Feb 26-2.81%
Feb 26-2.76%
Feb 26-2.99%
Feb 26-3.02%
Jan 26-2.72%
Jan 26-2.46%
Jan 26-2.4%
Jan 26-2.29%
Jan 26-2.15%
Dec 25-2.15%
Dec 25-2.37%
Dec 25-2.53%
Dec 25-2.21%
Nov 25-2.23%
Nov 25-2.23%
Nov 25-2.2%
Nov 25-2.46%
Oct 25-2.58%
Oct 25-18.8%
Oct 25-18.45%
Oct 25-16.37%
Oct 25-9.95%
Sep 25-24.71%
Sep 25-26.02%
Sep 25-25.85%
Sep 25-27.1%
Aug 25-28.89%
Aug 25-29.1%
Aug 25-30.46%
Aug 25-38.9%
Aug 25-36.38%
Jul 25-34.65%
Jul 25-36.37%
Jul 25-37.87%
Jul 25-37.87%
Jun 25-38.67%
Jun 25-40.81%
Jun 25-39.5%
Jun 25-39.93%
May 25-39.93%
May 25-38.26%
May 25-38.26%
May 25-38.26%
May 25-38.26%
Apr 25-55.31%
Apr 25-55.31%
Apr 25-56.03%
Apr 25-54.61%
Mar 25-53.93%
Mar 25-53.93%
Mar 25-47.94%
Mar 25-49.03%
Feb 25-44.02%
Feb 25-44.02%
Feb 25-45.42%
Feb 25-47.94%
Jan 25-46.9%
Jan 25-11.13%
Jan 25-12.12%
Jan 25-12.25%
Jan 25-11.85%
Dec 24-11.24%
Dec 24-11.24%
Dec 24-10.91%
Dec 24-11.6%
Nov 24-12.54%
Nov 24-14.16%
Nov 24-16.04%
Nov 24-14.54%
Nov 24-13.98%
Oct 24-14.13%
Price to Sales
2000300040005000med 3068.74Feb 17Apr 17Jun 17Aug 17Oct 17Dec 17Jan 18
HBP.TO Price to Sales by quarter
PeriodPrice to Sales
Jan 182934.69
Jan 182969.63
Jan 182934.69
Jan 182934.69
Dec 173284.06
Dec 172934.69
Dec 173004.56
Dec 172864.81
Dec 172934.69
Nov 172760
Nov 172864.81
Nov 172934.69
Nov 172934.69
Oct 172864.16
Oct 172864.16
Oct 173068.74
Oct 173068.74
Sep 173068.74
Sep 173068.74
Sep 173034.65
Sep 173068.74
Sep 173068.74
Aug 173068.74
Aug 173068.74
Aug 173068.74
Aug 172932.36
Jul 173020.7
Jul 173121.39
Jul 173020.7
Jul 173188.52
Jun 173188.52
Jun 173188.52
Jun 173322.77
Jun 173087.83
Jun 173356.33
May 173356.33
May 173222.08
May 173356.33
May 172953.57
Apr 172790.81
Apr 173217.64
Apr 173513.13
Apr 173578.8
Mar 173545.97
Mar 174268.29
Mar 174202.63
Mar 173939.96
Mar 174366.79
Feb 174563.79
Feb 174498.12
Feb 174760.79
Feb 174596.62
Price to Book
0255075100125med 18.27Dec 22Jul 23Oct 23Nov 25Feb 26Jun 26Sep 26
HBP.TO Price to Book by quarter
PeriodPrice to Book
Sep 267.28
Sep 267.54
Sep 269.36
Aug 269.88
Aug 2610.24
Aug 269.72
Aug 268.32
Jul 267.8
Jul 267.06
Jul 266.96
Jul 267.16
Jul 266.96
Jun 267.21
Jun 267.06
Jun 267.86
Jun 267.86
May 268.1
May 268.1
May 267.86
May 268.15
May 2610.49
Apr 269.21
Apr 269.4
Apr 268.88
Apr 268.03
Mar 268.69
Mar 267.79
Mar 269.4
Mar 269.82
Feb 269.3
Feb 269.44
Feb 268.74
Feb 268.64
Jan 269.59
Jan 269.99
Jan 2610.23
Jan 2610.75
Jan 2611.42
Dec 2511.42
Dec 2510.37
Dec 259.71
Dec 2511.13
Nov 2511.04
Nov 2511.04
Nov 2511.18
Nov 259.99
Oct 259.52
Apr 2471.86
Apr 2461.59
Apr 2465.01
Apr 2463.3
Mar 2461.59
Mar 2471.86
Mar 2465.01
Mar 2463.3
Mar 2463.3
Feb 2458.17
Feb 2458.17
Feb 2458.17
Feb 2466.72
Oct 2343.82
Oct 2341.62
Oct 2350.39
Oct 2346.01
Sep 2347.32
Sep 2352.58
Sep 2354.77
Sep 2352.58
Sep 2348.2
Aug 2344.69
Aug 2346.01
Aug 2346.01
Aug 2346.01
Jul 2318.81
Jul 2318.81
Jul 2319.7
Jul 2319.7
Jun 2318.81
Jun 2318.81
Jun 2317.91
Jun 2318.27
Jun 2318.81
May 2318.27
May 2318.81
May 2318.27
May 2317.91
Jan 23104.33
Jan 2394.17
Jan 23104.33
Jan 23101.56
Dec 2299.71
Dec 2292.32
Dec 2287.71
Dec 2299.71
Dec 2296.94
Nov 22101.56
Nov 22106.17
Nov 2296.94
Nov 2299.71
Oct 2154.94
Helix BioPharma Corp.
HBP.TO
Stockpicker

Video analysis: HBP.TO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.